Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

3.2%

17 terminated/withdrawn out of 538 trials

Success Rate

95.6%

+9.1% vs industry average

Late-Stage Pipeline

30%

161 trials in Phase 3/4

Results Transparency

12%

45 of 373 completed trials have results

Key Signals

26 recruiting45 with results14 terminated

Enrollment Performance

Analytics

N/A

225(49.5%)

Phase 3

108(23.7%)

Phase 2

57(12.5%)

Phase 4

53(11.6%)

Phase 1

12(2.6%)

455Total

N/A(225)

Phase 3(108)

Phase 2(57)

Phase 4(53)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (538)

Showing 20 of 538 trials

NCT07264088Not Yet Recruiting

Identifying the Best Follow up Approach for People Who Have Had Treatment to Cure Newly Diagnosed Prostate Cancer

Role: collaborator

NCT03555981Not ApplicableTerminated

Early Kangaroo Mother Care in Gambian Hospitalised Unstable Neonates

Role: lead

NCT07534267Not Yet Recruiting

Understanding MPXV Viral Clearance, Transmission Dynamics, and Mpox Vaccine Effectiveness in West Africa : Guinea

Role: lead

NCT06873243Not ApplicableActive Not Recruiting

Developing a Learning Health System for Primary Care in Thailand

Role: collaborator

NCT06640075Not ApplicableRecruiting

Community Co-produced Action for Improved Access to Cervical Cancer Screening in Cameroon

Role: collaborator

NCT07498829Not ApplicableRecruiting

Population Based Germline Testing for Early Detection and Prevention of Cancer

Role: collaborator

NCT06923592Phase 3Recruiting

Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar

Role: lead

NCT04149210Phase 3Completed

FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) Trial

Role: collaborator

NCT07488962Not ApplicableNot Yet Recruiting

Building Cognitive Resilience to Vaccine Misinformation Using AI: Evidence From a Randomised Trial

Role: lead

NCT05796193Not ApplicableActive Not Recruiting

Net Transition Initiative: Efficacy of Two Next-generation Nets for Control of Malaria in Cote d'Ivoire

Role: lead

NCT06834893Not ApplicableNot Yet Recruiting

Assessing the Effects of Cool Roofs on Indoor Environments and Health in Colima, Mexico

Role: collaborator

NCT04521881Phase 3Recruiting

Clinical Randomisation of an Anti-fibrinolytic in Symptomatic Mild Head Injury in Older Adults

Role: lead

NCT06831006Not ApplicableNot Yet Recruiting

Assessing the Effect of Cool Roofs on Health Using Smartwatches in Colima, Mexico

Role: collaborator

NCT06833736Not ApplicableCompleted

A Health App Using Recipes and Education Components to Facilitate Sustainable and Healthier Diets.

Role: lead

NCT07463040Phase 3Not Yet Recruiting

Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)

Role: collaborator

NCT06570993Not ApplicableCompleted

Assessing the Effects of Cool Roofs on Indoor Environments and Health in Niue

Role: collaborator

NCT06579950Not ApplicableRecruiting

Assessing the Effects of Cool Roofs on Indoor Environments and Health

Role: collaborator

NCT06571019Not ApplicableCompleted

Assessing the Effect of Cool Roofs on Health Using Smartwatches in Niue

Role: collaborator

NCT06579963Not ApplicableActive Not Recruiting

Assessing the Effect of Cool Roofs on Health Using Smartwatches

Role: collaborator

NCT04704830Phase 3Active Not Recruiting

R21/Matrix-M in African Children Against Clinical Malaria

Role: collaborator